Back to Superinvestors
SUPERINVESTOR HOLDERS

LLY

Eli Lilly and Company
Healthcare · Drug Manufacturers - General
Holders
12
Total value
$13,203,767,552
Total shares
11,008,369
Cross-link
Financials →
Investor Shares Value % of Portfolio Activity As of
PRIMECAP Management
PRIMECAP Management Co
9,172,904 $11,002,256,246 6.51% REDUCE -50,528 30 Jun 2026
Cliff Asness
AQR Capital Management
1,035,605 $1,242,135,647 0.43% ADD +180,185 30 Jun 2026
Hersh Cohen
ClearBridge Investments
483,528 $579,957,855 0.48% ADD +16,849 30 Jun 2026
Ron Baron
Baron Capital (BAMCO)
140,540 $168,567,892 0.25% ADD +55,474 30 Jun 2026
Larry Robbins
Glenview Capital Management
57,771 $69,292,271 1.26% NEW +57,771 30 Jun 2026
Dodge & Cox
Dodge & Cox
41,258 $49,486,083 0.03% REDUCE -754 30 Jun 2026
Mario Gabelli
GAMCO Investors
27,377 $32,836,795 0.29% ADD +1,038 30 Jun 2026
Joel Greenblatt
Gotham Asset Management
21,971 $26,352,677 0.06% ADD +5,796 30 Jun 2026
Stanley Druckenmiller
Duquesne Family Office
12,380 $14,849,000 0.28% NEW +12,380 30 Jun 2026
Eric Marshall
Hodges Capital Management
10,780 $12,929,512 0.86% ADD +2,167 30 Jun 2026
Murray Stahl
Horizon Kinetics LLC
3,824 $4,586,620 0.05% REDUCE -141 30 Jun 2026
Bill Nygren
Harris Associates LP
431 $516,954 0.00% REDUCE -19 30 Jun 2026